A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia
Clinical trial NCT00088621 · COMPLETED
Trial details
- NCT number
- NCT00088621
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2005-10-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.